Articles by David Miklowitz, PhD

Psychosocial Treatment of Bipolar Disorder

July 1, 2012

David Miklowitz, PhD Professor of Psychiatry, Director, Child and Adolescent Mood Disorders Program, UCLA Semel Institute, David Geffen School of Medicine, UCLA Dr. Miklowitz has disclosed that he receives book royalties from Guilford Publications and John Wiley and Sons. He has presented one paid CME presentation for GlaxoSmithKline. Dr. Balt has reviewed this article and found no evidence of bias in this educational activity.

Why should we as psychiatrists focus on the psychosocial aspects of bipolar disorder? Dr. Miklowitz explores the benefits of a treatment program that combines targeted psychosocial treatments and medication.

Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Treating Opioid Use Disorder—A Fact Book (2024)
All the tools you need to assess and treat patients struggling with opioid use disorder.
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

General Psychiatry
Psychopharm Secrets: What Patients Won’t Tell You
How to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.
Listen now